Vraj Rangrej and Adam Kittai
Apr 1, 2025, 02:06
Vraj Rangrej: Revolutionising Approaches to Lymphoma and CLL Therapies
Vraj Rangrej, Visiting medical student at NewYork-Presbyterian Hospital, shared a post on LinkedIn:
“Revolutionising Approaches to Lymphoma and CLL Therapies
“Richter Transformation in the Era of Targeted therapies” from leading expert Dr. Adam Kittai, MD of Icahn School of Medicine at Mount Sinai.
– Optimizing BTK and BCL2 inhibitors for high-risk disease
– Emerging CAR-T approaches
A huge shoutout to the incredible team.
Special Thanks to Dr. Adam Kittai.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 9, 2025, 18:18
Sep 9, 2025, 17:59
Sep 9, 2025, 17:43
Sep 9, 2025, 16:51
Sep 9, 2025, 15:59